This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

Androgen receptor

From Proteopedia

Revision as of 08:04, 4 July 2013 by Michal Harel (Talk | contribs)

(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)

Jump to: navigation, search

Image:2q7i.png

Crystal structure of human androgen receptor ligand binding domain complex with testosterone and FXXFF-type peptide 2q7i

Template:STRUCTURE 2q7i

Androgen receptor (AR) is a nuclear receptor which is activated by testosterone or 5-α-dihydrotestosterone (DHT) hormone. Upon binding the androgenic hormone it translocates to the nucleus where it acts as a DNA-binding transcription factor. The AR binds to a specific sequence of DNA called hormone response element. AR binds to other proteins in the nucleus causing up- or down gene regulation. AR exists in two isoforms. AR-B is full length 110 kDa and AR-A (87 kDa) lacks the N-terminal 187 amino acids. AR structure is composed of 5 domains -
A/B: N-terminal contains the activation functions and dimerization surface
C: DNA binding domain (DBD)
D: Hinge region between DBD and LBD
E: Ligand binding domain (LBD) which binds the N-terminal FXXFL motif
F: C-terminal domain

1 3D Structures of androgen receptor
- 1.1 AR DBD domain
- 1.2 AR LBD domain
2 See Also

3D Structures of androgen receptor

Updated on 04-July-2013

AR DBD domain

1r4i – rAR (mutant) + DNA – rat

AR LBD domain

AR LBD domain complex with testosterone or DHT

1i37 – rAR + DHT
1i38 – rAR (mutant) + DHT
2ama – hAR + DHT - human
1t7t – cAR + DHT - chimpanzee
2ylo, 2ylp, 2ylq, 3zqt, 4hlw – hAR + testosterone + benzoate derivative
2pio, 2pip, 2piq, 2pir, 2pit, 2piu, 2piv, 2piw, 2pix, 2pkl, 2qpy – hAR + DHT + small molecule
2yhd – hAR + testosterone + small molecule
2am9 – rAR + testosterone

Other AR LBD domain complexes

1e3g, 1xq3 – hAR + androgen
1gs4 – hAR (mutant) + corticosteroid
1z95, 3rlj – hAR + anti-androgen
2oz7, 3rll – hAR (mutant) + anti-androgen
2ax6, 2ax7, 2ax8 – hAR (mutant) + nonsteroidal ligand
2ax9, 2axa – hAR + nonsteroidal ligand
2amb, 2pnu – hAR + steroid
1xnn – rAR (mutant) + nonsteroidal ligand
2ihq, 2nw4, 3g0w – rAR + modulator
2hvc, 3b5r, 3b65, 3b66, 3b67, 3b68 – hAR + modulator

AR LBD domain complex with peptide

1t73, 1t74, 1t76, 1t79, 1t7f, 1t7m, 1t7r – cAR + FXXFF-type peptide
1xow – hAR + androgen + FXXFF-type peptide
2q7i – hAR + testosterone + FXXFF-type peptide
3v49, 3v4a – hAR + modulator + FXXFF-type peptide
1t5z – hAR + DHT + nuclear receptor coactivator 1 peptide
1t63, 1t65 – hAR + DHT + nuclear receptor coactivator 2 peptide
3l3x, 3l3z – hAR + DHT + nuclear receptor coactivator 3 peptide
2z4j – hAR + DHT + nuclear receptor 0B2 peptide
2q7j – hAR + testosterone + nuclear receptor coactivator 2 peptide
2q7k, 2q7l – hAR (mutant) + testosterone + nuclear receptor coactivator 2 peptide
2ao6 – hAR + nuclear receptor coactivator 2 peptide
1xj7 – hAR + DHT + RAC3 peptide